https://orcid.org/0000-0003-1736-4719
References
- Park HS, Choi JW, Kim BK, Cho KH. Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies. Am J Dermatopathol. 2010;32(1):24–30. doi:10.1097/DAD.0b013e3181b4a5ec
- Rangel LK, Villa-Ruiz C, Lo K, et al. Clinical characteristics of lupus erythematosus panniculitis/profundus: a retrospective review of 61 patients. JAMA Dermatol. 2020;156(11):1264. doi:10.1001/jamadermatol.2020.2797
- Ng PP, Tan SH, Tan T. Lupus erythematosus panniculitis: a clinicopathologic study. Int J Dermatol. 2002;41(8):488–490. doi:10.1046/j.1365-4362.2002.01510.x
- Chanprapaph K, Tankunakorn J, Suchonwanit P, Rutnin S. Dermatologic manifestations, histologic features and disease progression among cutaneous lupus erythematosus subtypes: a prospective observational Study in Asians. Dermatol Ther. 2021;11(1):131–147. doi:10.1007/s13555-020-00471-y
- Elbendary A, Griffin J, Li S, Tlougan B, Junkins-Hopkins JM. Linear sclerodermoid lupus erythematosus profundus in a child. Am J Dermatopathol. 2016;38(12):904–909. doi:10.1097/DAD.0000000000000663
- Schwartz Z, Magro CM. Intralesional overlap syndrome: sclerodermic lupus panniculitis and sclerodermic discoid lupus erythematosus. JAAD Case Rep. 2020;6(3):166–168. doi:10.1016/j.jdcr.2019.10.018
- Stork J, Vosmik F. Lupus erythematosus panniculitis with morphea-like lesions. Clin Exp Dermatol. 1994;19(1):79–82. doi:10.1111/j.1365-2230.1994.tb01125.x
- Marzano AV, Tanzi C, Caputo R, Alessi E. Sclerodermic linear lupus panniculitis: report of two cases. Dermatology. 2005;210(4):329–332. doi:10.1159/000084760
- Umbert P, Winkelmann RK. Concurrent localized scleroderma and discoid lupus erythematosus. Cutaneous ‘mixed’ or ‘overlap’ syndrome. Arch Dermatol. 1978;114(10):1473–1478. doi:10.1001/archderm.1978.01640220022005
- Frangou E, Chrysanthopoulou A, Mitsios A, et al. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A). Ann Rheum Dis. 2019;78(2):238–248. doi:10.1136/annrheumdis-2018-213181
- Safi R, Al-Hage J, Abbas O, Kibbi AG, Nassar D. Investigating the presence of neutrophil extracellular traps in cutaneous lesions of different subtypes of lupus erythematosus. Exp Dermatol. 2019;28(11):1348–1352. doi:10.1111/exd.14040
- Sole C, Gimenez-Barcons M, Ferrer B, Ordi-Ros J, Cortes-Hernandez J. Microarray study reveals a transforming growth factor-beta-dependent mechanism of fibrosis in discoid lupus erythematosus. Br J Dermatol. 2016;175(2):302–313. doi:10.1111/bjd.14539
- O’Brien JC, Hosler GA, Chong BF. Changes in T cell and B cell composition in discoid lupus erythematosus skin at different stages. J Dermatol Sci. 2017;85(3):247–249. doi:10.1016/j.jdermsci.2016.12.004
- Francois A, Chatelus E, Wachsmann D, et al. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res Ther. 2013;15(5):R168. doi:10.1186/ar4352
- Julia M, Mascaro JM Jr, Guilabert A, Navarra E, Ferrando J, Herrero C. Sclerodermiform linear lupus erythematosus: a distinct entity or coexistence of two autoimmune diseases? J Am Acad Dermatol. 2008;58(4):665–667. doi:10.1016/j.jaad.2007.06.044